NKS Med Ltd 11914292 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is the provision of medical services. Digita Accounts Production Advanced 6.30.9574.0 true true 11914292 2023-04-01 2024-03-31 11914292 2024-03-31 11914292 core:RetainedEarningsAccumulatedLosses 2024-03-31 11914292 core:ShareCapital 2024-03-31 11914292 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 11914292 core:FurnitureFittingsToolsEquipment 2024-03-31 11914292 bus:SmallEntities 2023-04-01 2024-03-31 11914292 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11914292 bus:FullAccounts 2023-04-01 2024-03-31 11914292 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11914292 bus:RegisteredOffice 2023-04-01 2024-03-31 11914292 bus:Director1 2023-04-01 2024-03-31 11914292 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11914292 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 11914292 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 11914292 countries:England 2023-04-01 2024-03-31 11914292 2023-03-31 11914292 core:FurnitureFittingsToolsEquipment 2023-03-31 11914292 2022-04-01 2023-03-31 11914292 2023-03-31 11914292 core:RetainedEarningsAccumulatedLosses 2023-03-31 11914292 core:ShareCapital 2023-03-31 11914292 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 11914292 core:FurnitureFittingsToolsEquipment 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 11914292

NKS Med Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

NKS Med Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

NKS Med Ltd

(Registration number: 11914292)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

1,037

1,184

Current assets

 

Cash at bank and in hand

 

58,482

18,226

Creditors: Amounts falling due within one year

(10,300)

(4,386)

Net current assets

 

48,182

13,840

Net assets

 

49,219

15,024

Capital and reserves

 

Called up share capital

10

10

Profit and loss account

49,209

15,014

Total equity

 

49,219

15,024

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 30 November 2024
 

Dr N Stewart

Director

 

NKS Med Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the director on 30 November 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

NKS Med Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

25% SL

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2023 - 2).

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2023

3,507

3,507

Additions

381

381

At 31 March 2024

3,888

3,888

Depreciation

At 1 April 2023

2,323

2,323

Charge for the year

528

528

At 31 March 2024

2,851

2,851

Carrying amount

At 31 March 2024

1,037

1,037

At 31 March 2023

1,184

1,184